Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02966639 · ClinicalTrials.gov registry record

Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis

A clinical trial of Spondylolisthesis, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
171
Enrollment target
1
Study location

NCT02966639: Completed study of Spondylolisthesis, sponsored by Dartmouth-Hitchcock Medical Center.

NCT02966639 is a study of Spondylolisthesis that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 171 participants, above the 143-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02966639, a study of Spondylolisthesis, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
171 participants
Enrollment target
1
Study location

Study Summary

The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according to the RAND Appropriateness Method (RAM) Criteria.

Conditions Studied

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2016-10
Est. Completion 2021-06-01
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT02966639 record still lists

NCT02966639 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, above the 143-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (20% higher).

The record links to 1 condition, with Spondylolisthesis appearing as the primary indexed condition, and to 0 interventions.

NCT02966639 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT02966639 about?

NCT02966639 is a clinical study titled "Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis". The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according...

What is the current status of trial NCT02966639?

This trial is currently completed. The enrollment target is 171 participants. The study started on 2016-10. Estimated completion is 2021-06-01.

What conditions does trial NCT02966639 study?

This clinical trial studies the following conditions: Spondylolisthesis.

Who is sponsoring clinical trial NCT02966639?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02966639 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolisthesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02966639's enrollment target sits among peer trials

171 5th of 18 higher than 14 of 18 other Spondylolisthesis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spondylolisthesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02966639, the US trial registry maintained by the National Library of Medicine. NCT02966639 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.